Introduction: The Convergence of AI and Life SciencesTraditionally, drug discovery is a time-consuming and costly process, ...

Engine Biosciences (Engine), a company pioneering cancer medicines informed by its proprietary machine learning and ...

In this interview, rare disease expert Oxana Iliach discusses challenges with rare disease drug development and how they can ...

This expanded engagement reflects years of collaboration and trust between the two companies. Through previous work together, ...

Local authorities have apprehended a 30-year-old man following a traffic stop investigation that led to the discovery of ...

While significant progress has been made in developing treatments for rare diseases—highlighted by the approval of over 800 ...

Recognizing the importance of credibility in translational research, the study outlines a stringent four-tier validation ...

Phenotypic screening has re-emerged as a powerful strategy for identifying drugs based on their observable effects. Discover ...

Synergistic application of AI-based generative chemistry and free energy methods streamlines molecule discovery and ...

Learn how in vitro models, biomarkers and modelling can improve prediction of drug interactions and toxicity - reducing false ...

This article was published by IBN, a multifaceted communications organization engaged in connecting public companies to the ...

Portland-based biotech company Araceli Biosciences raised $11.2 million in new funding to fuel the expansion of its ...